Command Palette

Search for a command to run...

COHANCE
916.2(+0.38%)
1W: -10.50%

Peers

Snapshot Summary

Cohance Lifesciences Ltd. demonstrates strong profitability with a substantial ROE, but its high PE ratio indicates it may be overvalued compared to peers. However, it has the lowest debt levels, making it a safer investment compared to others with higher debt ratios. Among its peers, Dr. Reddy's Laboratories stands out for its strong profitability and low valuation metrics, making it a potential value pick.

  • • Cohance Lifesciences has the lowest debt to equity ratio (0.0465), indicating low financial risk.
  • • Dr. Reddy's Laboratories offers strong profitability with a PE ratio of 15.50, making it a highly attractive value pick.
  • • Mankind Pharma shows the highest revenue growth YoY (18.12%) and 3-Year (155.25%), indicating excellent growth potential.
  • • Dr. Reddy's Laboratories Ltd.: Strong profitability metrics with high ROE and low valuation, making it a solid investment.
  • • Mankind Pharma Ltd.: Exceptional growth trajectory with the highest revenue growth and strong profitability.
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
COHANCE₹902.15₹22,965.58Cr127.0218.44%0.05
SUNPHARMA₹1,563.35₹3,75,099.26Cr87.5917.60%0.04
DIVISLAB₹6,091.05₹1,61,698.50Cr73.2016.46%-
CIPLA₹1,587.60₹1,28,217.27Cr23.7322.77%0.01
TORNTPHARM₹3,581.55₹1,21,215.77Cr61.5324.28%0.57
DRREDDY₹1,280.30₹1,06,835.27Cr15.5026.86%0.07
MANKIND₹2,518.95₹1,03,926.59Cr55.1828.38%0.02
Explore
Watchlists
Chat
Portfolio